Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysis
Language English Country Great Britain, England Media print-electronic
Document type Journal Article
- Keywords
- Substance use, accuracy, self-reported,
- MeSH
- Cannabinoid Receptor Agonists MeSH
- Adult MeSH
- Mass Spectrometry MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Substance Abuse Detection methods MeSH
- Substance-Related Disorders * diagnosis epidemiology MeSH
- Aged MeSH
- Emergency Service, Hospital MeSH
- Illicit Drugs * toxicity MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Cannabinoid Receptor Agonists MeSH
- Illicit Drugs * MeSH
CONTEXT: Acute toxicity caused by illicit substance use is a common reason for emergency department (ED) presentation. Knowledge of the substances involved is helpful for predicting and managing potential toxicity, but limited information is available about the accuracy of patient-reported substance exposure. This study assessed the accuracy of the history of exposure in those reporting use of a single substance by comparison with those identified by detailed toxicological analysis, focusing on synthetic cannabinoid receptor agonists (SCRA). METHODS: Adults (≥16 years) presenting between March 2015 and July 2021 to participating UK hospitals with toxicity after reporting use of a single illicit substance were included. Exposure details were documented from medical records and blood and/or urine samples analysed using high-resolution accurate mass liquid chromatography-mass spectrometry (HRAM LCMS). Sensitivity, specificity, and positive and negative predictive values of the exposure history were calculated by comparison with biological sample analysis ("gold standard"). RESULTS: Single substance exposure was reported for 474 (median age 33 years, IQR: 18 range 16-75, 80% males) patients. Analysis commonly identified multiple substances (Median 3, IQR 2-5). A history of exposure was documented for 121 of 151 patients where a SCRA or metabolite was detected on analysis (sensitivity 80.1%, 95% CI 72.9, 86.2%). Corresponding proportions were lower for 3,4-methylenedioxymethamphetamine (MDMA, 44/70, 62.9%., 95% CI 50.5%, 74.1%), heroin 41/108 (38.0% 95% CI 28.8-47.8%) and cocaine (22/56, 31.3%, 95% CI 20.9, 43.6%). CONCLUSIONS: Multiple undeclared substances were detected analytically in most patients reporting single substance use. Clinicians should be alert to the potential presence and toxicity of unreported substances when managing patients presenting after substance misuse.
Aberdeen Royal Infirmary Aberdeen UK
Blackpool Teaching Hospitals NHS Foundation Trust Blackpool UK
Epsom and St Helier University Hospitals NHS Trust Epsom UK
LGC Sport and Specialised Analytical Services Fordham UK
Medical Toxicology Centre Newcastle University Newcastle UK
Newcastle Hospitals NHS Foundation Trust and National Poisons Information Service Newcastle UK
Pharmacology Toxicology and Therapeutics University of Edinburgh Edinburgh UK
RECETOX Faculty of Science Masaryk University Brno Czech Republic
Royal Berkshire NHS Foundation Trust Reading UK
Scottish Police Authority Forensic Services Edinburgh UK
St George's University Hospitals NHS Foundation Trust London UK
References provided by Crossref.org